Figure 1: Analysis of CASC2 expression in both CRC tissues and cell lines. | Scientific Reports

Figure 1: Analysis of CASC2 expression in both CRC tissues and cell lines.

From: The long noncoding RNA CASC2 functions as a competing endogenous RNA by sponging miR-18a in colorectal cancer

Figure 1

(A) CASC2 was significantly down-regulated in 76% (52/68) of CRC tissues. The blue shading indicates the down-regulation of CASC2, and the data are presented as fold-change in tumor tissues relative to normal tissues. P < 0.001, paired t-test. (B) Different CASC2 expression levels in CRC tissues and adjacent normal tissues from 68 patients as assessed by real-time PCR. *P < 0.05, paired t-test. (C) Relative expression of CASC2 in five CRC cell lines (CACO2, SW480, SW620, HCT116 and HT-29) and non-tumorigenic human cell lines (CCC-HIE-2 and HER293). *P < 0.05, Two-side Student’s t-test; n = 3.

Back to article page